An Open-label, Single Arm, Phase 2 Study to Evaluate ABT-450/r/ABT-267 and ABT-333 With Ribavirin (RBV) in Adults With Genotype 1 HCV Infection Taking Methadone or Buprenorphine

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

September 30, 2014

Conditions

Chronic Hepatitis C InfectionChronic Hepatitis C

Interventions

DRUG

ABT-450/r/ABT-267

Tablet; ABT-450 coformulated with ritonavir and ABT-267

DRUG

ABT-333

Tablet

DRUG

Ribavirin (RBV)

Tablet